KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive top-line results from two pivotal Phase 3 trials of the ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from two pivotal Phase 3 trials of the investigational, ...

For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV ...

Antiretroviral therapy dynamics encompass the complex interplay between drug regimens, viral kinetics and host immune responses in the management of HIV infection. Since the introduction of ...

The number of people in South Africa on antiretroviral treatment remained roughly unchanged from 2024 to 2025, according to ...

Background: Current guidelines for the use of antiretroviral (ARV) therapy during pregnancy recommend that women be offered treatment with combination ARV therapy used in nonpregnant HIV-infected ...

South Africa’s HIV antiretroviral (ARV) therapy treatment programme has recorded its slowest growth in 20 years. According to ...

In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the ...

Median progression free survival of 3.7 months in all patients and 5.7 months in patients with ESR1 mutant tumors support the initiation of two Phase 3 registrational trials NEW HAVEN, Conn., Nov. 22, ...